129 related articles for article (PubMed ID: 38158377)
1. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive clinicopathological and molecular analysis of primary malignant melanoma of the oesophagus.
Tsuyama S; Kohsaka S; Hayashi T; Suehara Y; Hashimoto T; Kajiyama Y; Tsurumaru M; Ueno T; Mano H; Yao T; Saito T
Histopathology; 2021 Jan; 78(2):240-251. PubMed ID: 32654197
[TBL] [Abstract][Full Text] [Related]
3. Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications.
Dai J; Jia J; Zhang F; Liu K; Xi Y; Yuan P; Mao L; Bai X; Wei X; Wang B; Li J; Xu Y; Liu T; Chang S; Shao Y; Guo J; Ying J; Si L
Cancer Res Commun; 2024 May; 4(5):1351-1362. PubMed ID: 38695555
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas.
Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N
Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970
[TBL] [Abstract][Full Text] [Related]
5. Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy.
Dai J; Bai X; Gao X; Tang L; Chen Y; Sun L; Wei X; Li C; Qi Z; Kong Y; Cui C; Chi Z; Sheng X; Xu Z; Lian B; Li S; Yan X; Tang B; Zhou L; Wang X; Xia X; Guo J; Mao L; Si L
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36593066
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characterization of ten patients with primary malignant melanoma of the esophagus and literature review.
Zhou SL; Zhang LQ; Zhao XK; Wu Y; Liu QY; Li B; Wang JJ; Zhao RJ; Wang XJ; Chen Y; Wang LD; Kong LF
World J Gastrointest Oncol; 2022 Sep; 14(9):1739-1757. PubMed ID: 36187400
[TBL] [Abstract][Full Text] [Related]
7. Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review.
Sanlorenzo M; Ribero S; Osella Abate S; Mariani S; Strignano P; Salizzoni M; Savoia P; Fierro MT; Quaglino P
G Ital Dermatol Venereol; 2020 Oct; 155(5):680-682. PubMed ID: 33295742
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of NRAS Mutation, PD-L1 Expression and Amplification, and Overall Survival Analysis in 36 Primary Vaginal Melanomas.
Wang HY; Wu XY; Zhang X; Yang XH; Long YK; Feng YF; Wang F
Oncologist; 2020 Feb; 25(2):e291-e301. PubMed ID: 32043781
[TBL] [Abstract][Full Text] [Related]
9. SF3B1, NRAS, KIT, and BRAF Mutation; CD117 and cMYC Expression; and Tumoral Pigmentation in Sinonasal Melanomas: An Analysis With Newly Found Molecular Alterations and Some Population-Based Molecular Differences.
Wroblewska JP; Mull J; Wu CL; Fujimoto M; Ogawa T; Marszalek A; Hoang MP
Am J Surg Pathol; 2019 Feb; 43(2):168-177. PubMed ID: 30273197
[TBL] [Abstract][Full Text] [Related]
10. Results of surgical treatment for primary malignant melanoma of the esophagus: A multicenter retrospective study.
Dai L; Wang ZM; Xue ZQ; He M; Yuan Y; Shang XQ; Chen KN;
J Thorac Cardiovasc Surg; 2020 Mar; ():. PubMed ID: 32359897
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.
Heppt MV; Siepmann T; Engel J; Schubert-Fritschle G; Eckel R; Mirlach L; Kirchner T; Jung A; Gesierich A; Ruzicka T; Flaig MJ; Berking C
BMC Cancer; 2017 Aug; 17(1):536. PubMed ID: 28797232
[TBL] [Abstract][Full Text] [Related]
12. Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations.
Haugh AM; Osorio RC; Francois RA; Tawil ME; Tsai KK; Tetzlaff M; Daud A; Vasudevan HN
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611025
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series.
Sun H; Zhu N; Gong L; Lan L; Yu Z; Pan Z
Front Oncol; 2022; 12():858145. PubMed ID: 35847861
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of genetic profiling based on different anatomic sites in patients with mucosal melanoma who received or did not receive immune checkpoint inhibitors.
Wang HY; Liu Y; Deng L; Jiang K; Yang XH; Wu XY; Guo KH; Wang F
Cancer Cell Int; 2023 Aug; 23(1):187. PubMed ID: 37649078
[TBL] [Abstract][Full Text] [Related]
15. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
[TBL] [Abstract][Full Text] [Related]
16. Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract.
Cai YJ; Ke LF; Zhang WW; Lu JP; Chen YP
BMC Cancer; 2021 Jun; 21(1):677. PubMed ID: 34102999
[TBL] [Abstract][Full Text] [Related]
17.
Bai X; Kong Y; Chi Z; Sheng X; Cui C; Wang X; Mao L; Tang B; Li S; Lian B; Yan X; Zhou L; Dai J; Guo J; Si L
Clin Cancer Res; 2017 Oct; 23(20):6120-6127. PubMed ID: 28720667
[No Abstract] [Full Text] [Related]
18. Prognostic Roles of
Wróblewska JP; Dias-Santagata D; Ustaszewski A; Wu CL; Fujimoto M; Selim MA; Biernat W; Ryś J; Marszalek A; Hoang MP
Cells; 2021 Aug; 10(9):. PubMed ID: 34571863
[TBL] [Abstract][Full Text] [Related]
19. The immune response-related genomic alterations in patients with malignant melanoma.
Li L; Xiang T; Li X
Medicine (Baltimore); 2024 Apr; 103(17):e37966. PubMed ID: 38669390
[TBL] [Abstract][Full Text] [Related]
20. Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.
Chen Y; Chen G; Li J; Huang YY; Li Y; Lin J; Chen LZ; Lu JP; Wang YQ; Wang CX; Pan LK; Xia XF; Yi X; Chen CB; Zheng XW; Guo ZQ; Pan JJ
JAMA Netw Open; 2019 Sep; 2(9):e1911895. PubMed ID: 31539077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]